Abbott to hike production of lower-cost glucose monitors as diabetes soars

Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming to reach millions more patients worldwide, the company told Reuters.

from Reuters: Health News https://ift.tt/2k9iW3w
via IFTTT